{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:35:08Z","timestamp":1790393708432,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T00:00:00Z","timestamp":1728604800000},"content-version":"am","delay-in-days":315,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21H03095"],"award-info":[{"award-number":["21H03095"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.ajo.2023.05.022","type":"journal-article","created":{"date-parts":[[2023,6,17]],"date-time":"2023-06-17T05:55:06Z","timestamp":1686981306000},"page":"164-174","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Characteristics Related to Visual Acuity Loss After Successful Photodynamic Therapy for Eyes With Central Serous Chorioretinopathy"],"prefix":"10.1016","volume":"256","author":[{"given":"Ryoh","family":"Funatsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroto","family":"Terasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shozo","family":"Sonoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2208-2118","authenticated-orcid":false,"given":"Hideki","family":"Shiihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naohisa","family":"Mihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiji","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ajo.2023.05.022_bib0001","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1016\/S0161-6420(96)30386-2","article-title":"Central serous chorioretinopathy in younger and older adults","volume":"103","author":"Spaide","year":"1996","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.ajo.2023.05.022_bib0002","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00006982-199616030-00004","article-title":"Indocyanine green videoangiography of older patients with central serous chorioretinopathy","volume":"16","author":"Spaide","year":"1996","journal-title":"Retina"},{"issue":"10","key":"10.1016\/j.ajo.2023.05.022_bib0003","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1097\/IAE.0000000000001443","article-title":"Acute central serous chorioretinopathy: factors influencing episode duration","volume":"37","author":"Daruich","year":"2017","journal-title":"Retina"},{"issue":"11","key":"10.1016\/j.ajo.2023.05.022_bib0004","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1136\/bjo.68.11.815","article-title":"Long-term follow-up of central serous chorioretinopathy","volume":"68","author":"Gilbert","year":"1984","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2023.05.022_bib0005","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ophtha.2018.12.048","article-title":"Long-term visual outcomes and causes of vision loss in chronic central serous chorioretinopathy","volume":"126","author":"Mrejen","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2023.05.022_bib0006","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ajo.2020.10.011","article-title":"OCT risk factors for 3-year development of macular complications in eyes with \u201cresolved\u201d chronic central serous chorioretinopathy","volume":"223","author":"Borrelli","year":"2021","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"10.1016\/j.ajo.2023.05.022_bib0007","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.ophtha.2018.04.021","article-title":"Half-dose photodynamic therapy versus high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy: the PLACE trial","volume":"125","author":"van Dijk","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2023.05.022_bib0008","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ajo.2021.06.020","article-title":"Half-dose photodynamic therapy versus eplerenone in chronic central serous chorioretinopathy (SPECTRA): a randomized controlled trial","volume":"233","author":"van Rijssen","year":"2022","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2023.05.022_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2022.100152","article-title":"Effectiveness of reduced-fluence photodynamic therapy for chronic central serous chorioretinopathy: a propensity score analysis","volume":"2","author":"Aisu","year":"2022","journal-title":"Ophthalmol Sci"},{"key":"10.1016\/j.ajo.2023.05.022_bib0010","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ajo.2020.04.007","article-title":"Crossover to photodynamic therapy or micropulse laser after failure of primary treatment of chronic central serous chorioretinopathy: the REPLACE trial","volume":"216","author":"van Rijssen","year":"2020","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2023.05.022_bib0011","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ophtha.2013.09.024","article-title":"Low-fluence photodynamic therapy versus ranibizumab for chronic central serous chorioretinopathy: one-year results of a randomized trial","volume":"121","author":"Bae","year":"2014","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.ajo.2023.05.022_bib0012","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/aos.14775","article-title":"Long-term follow-up of chronic central serous chorioretinopathy after successful treatment with photodynamic therapy or micropulse laser","volume":"99","author":"van Rijssen","year":"2021","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.ajo.2023.05.022_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2019.07.003","article-title":"Central serous chorioretinopathy: towards an evidence-based treatment guideline","volume":"73","author":"van Rijssen","year":"2019","journal-title":"Prog Retin Eye Res"},{"issue":"2","key":"10.1016\/j.ajo.2023.05.022_bib0014","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/IAE.0b013e3182670fbe","article-title":"Photodynamic therapy for chronic central serous chorioretinopathy: a 4-year follow-up study","volume":"33","author":"Silva","year":"2013","journal-title":"Retina"},{"issue":"3","key":"10.1016\/j.ajo.2023.05.022_bib0015","doi-asserted-by":"crossref","first-page":"113","DOI":"10.4103\/2229-3485.100662","article-title":"What to use to express the variability of data: standard deviation or standard error of mean?","volume":"3","author":"Barde","year":"2012","journal-title":"Perspect Clin Res"},{"issue":"11","key":"10.1016\/j.ajo.2023.05.022_bib0016","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.ophtha.2022.06.017","article-title":"Impact of smoking on visual field progression in a long-term clinical follow-up","volume":"129","author":"Mahmoudinezhad","year":"2022","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.ajo.2023.05.022_bib0017","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.ajo.2015.03.005","article-title":"Luminal and stromal areas of choroid determined by binarization method of optical coherence tomographic images","volume":"159","author":"Sonoda","year":"2015","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"10.1016\/j.ajo.2023.05.022_bib0018","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1097\/IAE.0b013e3182680a66","article-title":"Type 1 (sub-retinal pigment epithelial) neovascularization in central serous chorioretinopathy masquerading as neovascular age-related macular degeneration","volume":"32","author":"Fung","year":"2012","journal-title":"Retina"},{"issue":"1","key":"10.1016\/j.ajo.2023.05.022_bib0019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/IAE.0000000000000331","article-title":"Pachychoroid neovasculopathy","volume":"35","author":"Pang","year":"2015","journal-title":"Retina"},{"issue":"1","key":"10.1016\/j.ajo.2023.05.022_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00006982-200302000-00001","article-title":"Cystoid macular degeneration in chronic central serous chorioretinopathy","volume":"23","author":"Iida","year":"2003","journal-title":"Retina"},{"issue":"4","key":"10.1016\/j.ajo.2023.05.022_bib0021","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ophtha.2017.09.028","article-title":"Consensus definition for atrophy associated with age-related macular degeneration on OCT: classification of atrophy report 3","volume":"125","author":"Sadda","year":"2018","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.ajo.2023.05.022_bib0022","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1097\/IAE.0000000000002580","article-title":"Fundus autofluorescence patterns in central serous chorioretinopathy","volume":"40","author":"Han","year":"2020","journal-title":"Retina"},{"issue":"5","key":"10.1016\/j.ajo.2023.05.022_bib0023","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1167\/iovs.06-1277","article-title":"Correlation between focal macular electroretinograms and angiographic findings after photodynamic therapy","volume":"48","author":"Ishikawa","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.ajo.2023.05.022_bib0024","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s10384-008-0613-z","article-title":"Severe choroidal ischemia following photodynamic therapy for pigment epithelial detachment and chronic central serous chorioretinopathy","volume":"53","author":"Lee","year":"2009","journal-title":"Jpn J Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajo.2023.05.022_bib0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0202549","article-title":"Correlation between redefined optical coherence tomography parameters and best-corrected visual acuity in non-resolving central serous chorioretinopathy treated with half-dose photodynamic therapy","volume":"13","author":"van Rijssen","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ajo.2023.05.022_bib0026","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2147\/OPTH.S115685","article-title":"Chronic central serous chorioretinopathy: long-term follow-up and vision-related quality of life","volume":"11","author":"Breukink","year":"2017","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2023.05.022_bib0027","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ajo.2009.01.018","article-title":"Outer nuclear layer thickness at the fovea determines visual outcomes in resolved central serous chorioretinopathy","volume":"148","author":"Matsumoto","year":"2009","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2023.05.022_bib0028","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00006982-200202000-00004","article-title":"Factors associated with reduced visual acuity during long-term follow-up of patients with idiopathic central serous chorioretinopathy","volume":"22","author":"Loo","year":"2002","journal-title":"Retina"},{"issue":"3","key":"10.1016\/j.ajo.2023.05.022_bib0029","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1167\/iovs.62.3.25","article-title":"Choroidal and retinal changes after systemic adrenaline and photodynamic therapy in non-human primates","volume":"62","author":"Cheong","year":"2021","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2023.05.022_bib0030","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0161-6420(96)30675-1","article-title":"Liposomal benzoporphyrin derivative verteporfin photodynamic therapy. Selective treatment of choroidal neovascularization in monkeys","volume":"103","author":"Kramer","year":"1996","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.ajo.2023.05.022_bib0031","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0161-6420(99)90401-3","article-title":"Verteporfin photodynamic therapy retreatment of normal retina and choroid in the cynomolgus monkey","volume":"106","author":"Reinke","year":"1999","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ajo.2023.05.022_bib0032","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1167\/iovs.05-0838","article-title":"Ocular changes after photodynamic therapy","volume":"47","author":"Tzekov","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.ajo.2023.05.022_bib0033","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.ajo.2003.11.059","article-title":"Acute severe visual acuity decrease after photodynamic therapy with verteporfin: case reports from randomized clinical trials-TAP and VIP report no. 3","volume":"137","author":"Arnold","year":"2004","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"10.1016\/j.ajo.2023.05.022_bib0034","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1001\/jamaophthalmol.2020.2443","article-title":"Comparison of ranibizumab with or without verteporfin photodynamic therapy for polypoidal choroidal vasculopathy: the EVEREST II randomized clinical trial","volume":"138","author":"Lim","year":"2020","journal-title":"JAMA Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2023.05.022_bib0035","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/IAE.0000000000003686","article-title":"Increasing evidence for the safety of fovea-involving half-dose photodynamic therapy for chronic central serous chorioretinopathy","volume":"43","author":"Feenstra","year":"2023","journal-title":"Retina"},{"issue":"2","key":"10.1016\/j.ajo.2023.05.022_bib0036","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s40123-020-00250-0","article-title":"Photodynamic therapy for chorioretinal diseases: a practical approach","volume":"9","author":"van Dijk","year":"2020","journal-title":"Ophthalmol Ther"},{"issue":"12","key":"10.1016\/j.ajo.2023.05.022_bib0037","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1136\/bjophthalmol-2021-319403","article-title":"Incidence of central serous chorioretinopathy (2011-2018): a nationwide population-based cohort study of Japan","volume":"106","author":"Kido","year":"2022","journal-title":"Br J Ophthalmol"},{"issue":"10","key":"10.1016\/j.ajo.2023.05.022_bib0038","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1038\/eye.2016.113","article-title":"Fundus autofluorescence imaging patterns in central serous chorioretinopathy according to chronicity","volume":"30","author":"Lee","year":"2016","journal-title":"Eye (Lond)"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939423002337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939423002337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T19:51:58Z","timestamp":1717185118000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939423002337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":38,"alternative-id":["S0002939423002337"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2023.05.022","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characteristics Related to Visual Acuity Loss After Successful Photodynamic Therapy for Eyes With Central Serous Chorioretinopathy","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2023.05.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}